Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Culclasure, T. F.
Right arrow Articles by Kruger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Culclasure, T. F.
Right arrow Articles by Kruger, M.

(Circulation. 1997;95:753.)
© 1997 American Heart Association, Inc.


Articles

Impending Paradoxical Embolus

Talley F. Culclasure, MD; Mitchel Kruger, MD

the Cardiology Service, Fitzsimons Army Medical Center, Aurora, Colo.

Correspondence to Talley F. Culclasure, MD, Cardiology Service, Department of Medicine, Fitzsimons Army Medical Center, Aurora, CO 80045-5001.


*    Introduction
 
A 61-year-old man was admitted for evaluation of progressive dyspnea several months after coronary artery bypass surgery. Ventilation-perfusion lung scanning revealed perfusion defects compatible with multiple pulmonary emboli. Transthoracic echocardiography was remarkable for normal left ventricular function, dilated right heart chambers, elevated pulmonary pressures, and a free-floating right atrial thrombus. Transesophageal echocardiography demonstrated free-floating right atrial thrombus with migration of the snakelike clot through a patent foramen ovale (Figure).

The patient's surgical risk for removal of the clot was increased by his prior surgery and elevated pulmonary pressures. Because of this, he was treated with a peripheral intravenous infusion of 100 mg of tissue plasminogen activator over 2 hours without a bolus. Repeat transthoracic echocardiography 4 hours after and transesophageal echocardiography 24 hours after initiation of thrombolytic therapy revealed no evidence of the thrombus and a dramatic improvement in right ventricular chamber size and pulmonary pressures. There was no evidence of systemic embolization, and the patient was discharged several days later on oral anticoagulation medication.



View larger version (50K):
[in this window]
[in a new window]
 
Figure 1. Transesophageal echocardiogram demonstrating free-floating thrombus (T and small arrow) in the right atrium (RA) with migration through the patent foramen ovale (large arrow) into the left atrium (LA).


*    Footnotes
 
The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.

Circulation encourages readers to submit cardiovascular images to Dr Hugh A. McAllister, Jr, St Luke's . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
V. Aboyans, P. Lacroix, E. Ostyn, E. Cornu, and M. Laskar
Diagnosis and management of entrapped embolus through a patent foramen ovale
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 624 - 628.
[Abstract] [Full Text] [PDF]